Non-genetic optoelectronic modulation biointerfaces for advancing healthcare
Peer-Reviewed Publication
Updates every hour. Last Updated: 28-Apr-2025 22:08 ET (29-Apr-2025 02:08 GMT/UTC)
The perspective discusses the transformative role of non-genetic optoelectronic modulation biointerfaces in modern medicine. These biointerfaces seamlessly blend light and electronics to offer potentially groundbreaking solutions for precise stimulation and monitoring of biological systems, significantly advancing both diagnostics and therapeutics.
A recent study highlights the health benefits of a cocoa-flavored, soy-based powder drink mix enriched with hydrolysates from edible bird's nests.
In a paper published in MedComm-Oncology, an international team of scientists present evidence of fossilized cell nuclei and chromosomes within preserved cartilage in a baby duck-billed dinosaur. This dinosaur belongs to Hypacrosaurus and comes from a nesting ground discovered in 1988 by paleontologist Jack Horner in Late Cretaceous sediments of Northwest Montana.
Military and civilian emergency thermochromic applications require rapid visible-light stealth (VLS); however, concurrent smart solar transmission and rapid VLS is yet to be realized. Inspired by squid-skin, a new mechanism of biomimetic thermal phase transformation coupled with forced-induced morphology transformation to regulate full-dimensional (frequency, space and angle) thermal radiation was constructed. It has solved the difficulty of compatibility between smart photothermal regulation and rapid VLS, and shortened the response time from traditional 180 seconds to 1 second.
Recent research confirms that the gut microbiome plays a causal role in various chronic diseases, including infections, cancer, and inflammatory disorders, highlighting its potential as a therapeutic target. This review synthesizes evidence from randomized controlled trials, showing how microbiome therapies such as fecal microbiota transplantation (FMT) can reduce infection recurrence, improve immunotherapy response, and support remission in inflammatory conditions. The findings emphasize the microbiome’s promising role in future, non-invasive treatments for chronic disease management.